Diantha Duvall
CIK 1696784 · CFO · last filed 2026-03-23
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$32.7K
Companies
3
Total Filings
25
Lifetime Open-Market Net
-$55.8K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CRIS | CFO | 77,707 | $0.42 | $32.7K | $0 | 6 | 2026-03-23 |
| GENOCEA BIOSCIENCES, INC. (GNCA) Delisted | CHIEF FINANCIAL OFFICER | 75,388 | $0.00 | $45 | -$6.3K | 8 | 2022-06-03 |
| Bioverativ Inc. (BIVV) Delisted | Chief Accounting Officer | 0 | — | — | -$49.5K | 11 | 2018-03-08 |
Recent Filings · Page 3 of 3
25 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-05-03 | Bioverativ Inc. (BIVV) Delisted | Tax (F) | −99 | -$5.7K | EDGAR |
| 2017-03-27 | Bioverativ Inc. (BIVV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-03-03 | Bioverativ Inc. (BIVV) Delisted | Tax (F) | −113 | -$6.0K | EDGAR |
| 2017-03-02 | Bioverativ Inc. (BIVV) Delisted | Mixed | +3,149 | -$10.1K | EDGAR |
| 2017-02-16 | Bioverativ Inc. (BIVV) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 21–25 of 25
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.